Strategy for advanced hepatocellular carcinoma unresponsive to transcatheter arterial chemoembolization using epirubicin

Japanese Journal of Cancer and Chemotherapy

Volumn 37, Issue 3, 2010, Pages 402-407

  Kawamura, Yusuke ^a   Ikeda, Kenji ^a   Kumada, Hiromitsu ^a  

^a TORANOMON HOSPITAL   (Japan)

Author keywords

Hepatocellular carcinoma; Platinum derivative; Transcatheter arterial chemoembolization; Unresponsive

Indexed keywords

EPIRUBICIN; IODINATED POPPYSEED OIL; MITOMYCIN C;

ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CHEMOEMBOLIZATION; DRUG EFFICACY; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; SURVIVAL RATE; TREATMENT RESPONSE;

EID: 79960829250     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Wheeler PG, Melia W, Dubbins P, et al: Non-operative arterial embolization in primary liver tumours. Br Med J 2: 242-244, 1979. (Pubitemid 9236898)
2. Chuang VP and Wallace S: Hepatic arterial embolization in the treatment of hepatic neoplasms. Radiology 140: 51-58, 1981. (Pubitemid 11067714)
3. Okamura J, Horikawa S, Fujiyama T, et al: An appraisal of transcatheter arterial infusion of chemotherapeutic agent for hepatic malignancies. World J Surg 6: 352-357, 1982.
4. Yamada R, Sato M, Kawabata M, et al: Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 148: 397-401, 1983. (Pubitemid 13073577)
5. Lin DY, Liaw YF, Lee TY, et al: Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma: A randomized controlled trial. Gastroenterology 94: 453-456, 1988.
6. Ikeda K, Kumada H, Saitoh S, et al: Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. Cancer 68: 2150-2154, 1991.
7. Llovet JM, Real MI, Montaña X, et al: Barcelona Liver Cancer Group. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359: 1734-1739, 2002.
8. Lo CM, Ngan H, Tso WK, et al: Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35: 1164-1171, 2002. (Pubitemid 34454013)
9. Kawamura Y, Ikeda K, Hirakawa M, et al: Efficacy of platinum analogue for advanced hepatocellular carcinoma unresponsive to transcatheter arterial chemoembolization with epirubicin. Hepatol Res 39: 346-354, 2009.
10. Demachi H, Matsui O, Abo H, et al: Simulation model based on non-newtonian fluid mechanics applied to the evaluation of the embolic effect of emulsions of iodized oil and anticancer drug. Cardiovasc Intervent Radiol 23: 285-290, 2000.
11. Yi SW, Kim YH, Kwon IC, et al: Stable lipiodolized emulsions for hepatoma targeting and treatment by transcatheter arterial chemoembolization. J Control Release 50: 135-143, 1998. (Pubitemid 28044108)
12. Imaoka S, Sasaki Y, Shibata T, et al: A pre-operative chemoembolization therapy using lipiodol, cisplatin and gelatin sponge for hepatocellular carcinoma. Cancer Chemother Pharmacol 23 Suppl: S126, 1989.